← All trials
NCT05460377
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 26, 2022
- Primary completion
- Mar 31, 2024
- Completion date
- Mar 31, 2024
- First posted
- Jul 15, 2022
- Last posted
- Oct 6, 2022
- Enrollment
- 1224
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Centers for Disease Control and Prevention (CDC)Lead sponsor
- Centers for Disease Control and Prevention, ChinaCollaborator
- World Health OrganizationCollaborator
- International Center for Diarrheal Disease ResearchCollaborator
- International Center for Diarrheal Disease ResearchOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.